Enhancement of mitomycin C-induced apoptosis in Nrf2-deficient human colon cancer cells

Molecular and Cellular Toxicology

Volumn 6, Issue 1, 2010, Pages 51-56

  Park, Jee Yeon ^a   Seo, Young R ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

DNA damage; Human colon cancer; Mitomycin C; Nuclear erythroid factor 2 related factor 2; Oxidative stress

Indexed keywords

EID: 77956759885     PISSN: 1738642X     EISSN: 20928467     Source Type: Journal    
DOI: 10.1007/s13273-010-0007-4     Document Type: Article

References (23)

1. Bradner, W.T.Mitomycin C: a clinical update.Cancer Treatment Reviews 27:35-50 (2001).
2. Tomasz, M.et al.Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA.Science 235:1204-1208 (1987).
3. Komiyama, T.et al.Generation of hydroxyl radical by anticancer quinine drugs, carbazilquinone, mitomycin C, aclacinomycin A and adriamycin, in the presence of NADPH-cytochrome P-450 reductase.Biochem Pharmacol 31:3651-3656 (1982).
4. Butler, J.et al.Reactions of the semiquinone free radicals of anti-tumouragents with oxygen and iron complexes.FEBS Lett 182:95-98 (1985).
5. Park, H.K.et al.Mitomycin C-induced cell death in mouse lens epithelial cells.Ophthalmic Res 34:213-219 (2002).
6. Zhang, D.D.Mechanistic studies of the Nrf2-Keap1 signaling pathway.Drug Metab Rev 38:769-789 (2006).
7. Venugopal, R.et al.Nrf1 and Nrf2 positively and c- Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H: quinone oxidoreductase1 gene.Proc Natl Acad Sci USA 93:14960-14965 (1996).
8. Ramos-Gomez, M.et al.Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice.Proc Natl Acad Sci USA 98:3410-3415 (2001).
9. Chan, K.et al.An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen.Proc Natl Acad Sci USA 98:4611-4616 (2001).
10. Hu, X.et al.Accelerated ovarian failure induced by 4-vinyl cyclohexene diepoxide in Nrf2 null mice.Mol Cell Biol 26:940-954 (2006).
11. Alexandria, L.et al.Dual roles of Nrf2 in cancer.Pharmacological Research 58:262-270 (2008)
12. Jaiswal, A.K.Nrf2 signaling in coordinated activation of antioxidant gene expression.Free Radic Biol Med 36:1199-1207 (2004).
13. Hayashi, A.et al.Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts.Biochem Biophys Res Commun 310:824-829 (2003).
14. Vollrath, V.et al.Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene.Biochem J 395:599-609 (2006).
15. Cho, J.M.et al.Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: Implication to cancer cell resistance.Cancer Letters 260: 96-108 (2008).
16. Grogan, T.M.et al.Thioredoxin, a putative oncogene product, is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival.Hum Pathol 31:475-481 (2000).
17. Soini, Y.et al.Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.Clin Cancer Res 7:1750-1757 (2001). (Pubitemid 32708645)
18. Lehtonen, S.T.et al.Variable overoxidation of peroxiredoxins in human lung cells in severe oxidative stress.Am J Physiol Lung Cell Mol Physiol 288:997-1001 (2005).
19. Wang, X.J.et al.Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2.Carcinogenesis 29:1235-1243 (2008).
20. Homma, S.et al.Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer.Clin Cancer Res 15:3423-3432 (2009).
21. Rotilio, G.et al.Biochemical mechanism of oxidative damage by redox-cycling drugs.Environ Health Perspect 64:259-264 (1985).
22. Akhdara, H.et al.Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells.European Journal of Cancer 45:2219-2227 (2009).
23. Stacy, D.R.et al.Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck squamous cell carcinomas.Head Neck 28:813-818 (2006)